STRIDES PHARMA SCIENCE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 886.6 INR | -1.14% |
|
+1.12% | +36.55% |
| Apr. 30 | Strides Pharma Science Limited Approves Appointment of Ameet P Hariani as Independent Director | CI |
| Apr. 09 | Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs | MT |
Evolution of the average Target Price on Strides Pharma Science Limited
Price target over the last 5 years
History of analyst recommendation changes
08d0d1cfcfe7356bdf41190d916a.O9u7KPdd5Qx5udnj6ttJFru6xZaIlpkAaG_CFPm408o.UoPqbcA4tlMs2qC7qYkWfc71jsS82s9CLgWjJozpuoUOvtJRkh_UZRHW4Q~ec9bbab32d2ff139b4ea2675917cc73e
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
886.6
INR
Average target price
830.5
INR
Spread / Average Target
-6.32%
High Price Target
965
INR
Spread / Highest target
+8.85%
Low Price Target
710
INR
Spread / Lowest Target
-19.91%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- STAR Stock
- Consensus Strides Pharma Science Limited
